Exp Mol Med.
2017 Sep;49(9):e376. 10.1038/emm.2017.134.
Comparative global immune-related gene profiling of somatic cells, human pluripotent stem cells and their derivatives: implication for human lymphocyte proliferation
- Affiliations
-
- 1College of Medicine, Graduate Institute of Immunology, National Taiwan University, Taipei, Taiwan. hnho@ntu.edu.tw
- 2Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan. hfchen@ntu.edu.tw
- 3College of Medicine, Graduate Institute of Medical Genomics and Proteomics, National Taiwan University, Taipei, Taiwan.
- 4Genome and Systems Biology Degree Program, National Taiwan University, Taipei, Taiwan.
- 5Department of Environmental Health, Harvard University – Harvard T.H. Chan School of Public Health, Molecular and Integrative Physiological Sciences, Boston, MA, USA.
- 6Department of Environment Health Science, University of California, Los Angeles, Los Angeles, CA, USA.
- 7Institute of Biotechnology, National Taiwan University, Taipei, Taiwan.
- 8Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.
- KMID: 2394307
- DOI: http://doi.org/10.1038/emm.2017.134
Abstract
- Human pluripotent stem cells (hPSCs), including embryonic stem cells (ESCs) and induced PSCs (iPSCs), represent potentially unlimited cell sources for clinical applications. Previous studies have suggested that hPSCs may benefit from immune privilege and limited immunogenicity, as reflected by the reduced expression of major histocompatibility complex class-related molecules. Here we investigated the global immune-related gene expression profiles of human ESCs, hiPSCs and somatic cells and identified candidate immune-related genes that may alter their immunogenicity. The expression levels of global immune-related genes were determined by comparing undifferentiated and differentiated stem cells and three types of human somatic cells: dermal papilla cells, ovarian granulosa cells and foreskin fibroblast cells. We identified the differentially expressed genes CD24, GATA3, PROM1, THBS2, LY96, IFIT3, CXCR4, IL1R1, FGFR3, IDO1 and KDR, which overlapped with selected immune-related gene lists. In further analyses, mammalian target of rapamycin complex (mTOR) signaling was investigated in the differentiated stem cells following treatment with rapamycin and lentiviral transduction with specific short-hairpin RNAs. We found that the inhibition of mTOR signal pathways significantly downregulated the immunogenicity of differentiated stem cells. We also tested the immune responses induced in differentiated stem cells by mixed lymphocyte reactions. We found that CD24- and GATA3-deficient differentiated stem cells including neural lineage cells had limited abilities to activate human lymphocytes. By analyzing the transcriptome signature of immune-related genes, we observed a tendency of the hPSCs to differentiate toward an immune cell phenotype. Taken together, these data identify candidate immune-related genes that might constitute valuable targets for clinical applications.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Engineering Biomaterials for Feeder-Free Maintenance of Human Pluripotent Stem Cells
- Neuronal Differentiation of a Human Induced Pluripotent Stem Cell Line (FS-1) Derived from Newborn Foreskin Fibroblasts
- Modeling of Human Genetic Diseases Via Cellular Reprogramming
- Human Placenta-Derived ECM Supports Tri-Lineage Differentiation of Human Induced Pluripotent Stem Cells
- Stem Cell ; New Paradigm in the Era of Genomic Medicine
